Artificial Intelligence-assisted Endoscopy and Examiner Confidence: A Study on Human-Artificial Intelligence Interaction in Barrett's Esophagus (With Video). [PDF]
DEN OpenABSTRACT Objective Despite high stand‐alone performance, studies demonstrate that artificial intelligence (AI)‐supported endoscopic diagnostics often fall short in clinical applications due to human‐AI interaction factors. This video‐based trial on Barrett's esophagus aimed to investigate how examiner behavior, their levels of confidence, and system ...
Roser D +13 more
europepmc +2 more sources
Pilot randomized crossover study comparing the efficacy of transnasal disposable endosheath with standard endoscopy to detect Barrett's esophagus. [PDF]
, 2015 BACKGROUND AND STUDY AIMS: The transnasal endosheath endoscope is a new disposable technology with potential applicability to the primary care setting.
Abdullahi, Zarah +6 more
core +2 more sources
Molecular Cancer, 2006 Background Barrett's esophagus, a risk factor for esophageal adenocarcinoma, is associated with reflux disease. The aim of this study was to assess the expression of bile acid receptors in the esophagus (normal, esophagitis, Barrett's esophagus and ...
Frossard Jean-Louis +10 more
doaj +1 more source
Gastroenterology Clinics of North America, 2008 Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma. Since most patients with Barrett's esophagus are undiagnosed and patients present with advanced adenocarcinoma de novo, prognosis for this disease remains poor. To identify those people with Barrett's esophagus who are at particular risk many new technologies are ...
Bird-Lieberman, E, Fitzgerald, R
openaire +3 more sources
Molecular biomarkers and ablative therapies for Barrett’s esophagus [PDF]
, 2012 Author version made available in accordance with the publisher's policy.Barrett’s esophagus is the major risk factor for esophageal adenocarcinoma. Endoscopic interventions which ablate Barrett’s esophagus mucosa lead to replacement with a new squamous ...
Chisolm, Jacob A +3 more
core +1 more source
Review: Diagnosis and management of Barrett’s esophagus for the endoscopist
Therapeutic Advances in Gastroenterology, 2010 In Barrett’s esophagus, the stratified squamous epithelium lining the esophagus is replaced by specialized intestinal-type columnar epithelium. The prevalence of Barrett’s esophagus has ranged from 0.9% to 4.5%.
Sagar S. Garud +3 more
doaj +1 more source
Barrett's esophagus: Ten years of experience at a tertiary care hospital center in Mexico
Revista de Gastroenterología de México (English Edition), 2018 Introduction: The prevalence of Barrett's esophagus has been calculated at between 1.3 and 1.6%. There is little information with respect to this in Mexico.
F. Valdovinos-Andraca +7 more
doaj +1 more source
Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma [PDF]
, 2015 Author version made available following 12 month embargo from date of publication according to publisher copyright policy.Barrett's esophagus (BE), a common condition, is the only known precursor to esophageal adenocarcinoma (EAC).
Appleyard, Mark +39 more
core +1 more source
Barrett’s Esophagus in Patients with Gastroesophageal Reflux Disease
Journal of Nepal Health Research Council, 2018 Background: Barrett’s esophagus a is metaplasia of normal squamous cells that line the lower part of the esophagus and carries a major risk for adenocarcinoma of esophagus.
Khus Raj Dewan +3 more
doaj +1 more source
Aspects on endoscopic characterization and clinical management of Barrett's esophagus [PDF]
, 2017 Barrett's esophagus (BE) is considered to result from prolonged gastroesophageal reflux and is the only known precursor of esophageal adenocarcinoma. The clinical management of BE patients aims to control esophageal reflux to reduce mucosal injury and
Silva, Francisco Baldaque
core +2 more sources